Key result
Higher radiation doses (7 and 14 Gy) reduced doxorubicin tissue penetration depth after PIPAC in an ex-vivo model.
Why the study?
Does irradiation affect the tissue penetration depth of doxorubicin delivered via PIPAC in an ex-vivo swine peritoneum model?
Does irradiation affect the tissue penetration depth of doxorubicin delivered via PIPAC in an ex-vivo swine peritoneum model?
Higher fractional radiation doses (7 and 14 Gy) reduce the tissue penetration depth of doxorubicin delivered via PIPAC in an ex-vivo swine model, whereas lower doses (1 and 2 Gy) do not.
Answers are grounded in this paper and cite their sources.
High-dose irradiation may reduce doxorubicin penetration after PIPAC in ex-vivo tissue; hypothesis-generating and requires in-vivo validation before clinical consideration.
BACKGROUND: This study was performed to assess the impact of irradiation on the tissue penetration depth of doxorubicin delivered during Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC). METHODS: Fresh post mortem swine peritoneum was cut into 10 proportional sections. Except for 2 control samples, all received irradiation with 1, 2, 7 and 14 Gy, respectively. Four samples received PIPAC 15 minutes after irradiation and 4 other after 24 hours. Doxorubicin was aerosolized in an ex-vivo PIPAC model at 12 mmHg/36°C. In-tissue doxorubicin penetration was measured using fluorescence microscopy on frozen thin sections. RESULTS: Doxorubicin penetration after PIPAC (15 minutes after irradiation) was 476 ± 74 µm for the control sample, 450 ± 45µm after 1 Gy (p > 0.05), 438 ± 29 µm after 2 Gy (p > 0.05), 396 ± 32 µm after 7 Gy (p = 0.005) and 284 ± 57 after 14 Gy irradiation (p < 0.001). The doxorubicin penetration after PIPAC (24 hours after irradiation) was 428 ± 77 µm for the control sample, 393 ± 41 µm after 1 Gy (p > 0.05), 379 ± 56 µm after 2 Gy (p > 0.05), 352 ± 53 µm after 7 Gy (p = 0.008) and 345 ± 53 after 14 Gy irradiation (p = 0.001). CONCLUSIONS: Higher (fractional) radiation dose might reduce the tissue penetration depth of doxorubicin in our ex-vivo model. However, irradiation with lower (fractional) radiation dose does not affect the tissue penetration negatively. Further studies are warranted to investigate if irradiation can be used safely as chemopotenting agent for patients with peritoneal metastases treated with PIPAC.
No takes yet. Share an insight, caveat, or question.
Khosrawipour et al. (2016) studied this question. Irradiation prior to Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. No irradiation (control) was evaluated on In-tissue doxorubicin penetration depth (µm) (p=<0.001). Higher radiation doses (7 and 14 Gy) reduced doxorubicin tissue penetration depth after PIPAC in an ex-vivo model.
Synapse has enriched 10 related papers. Consider them for comparative context: